🔴 Moleculin Biotech is trading 6.7% down in after-hours trading with no verified company-specific negative announcement identified

Moleculin Biotech is trading 6.7% down at $0.42 after-hours, with no verified company-specific negative announcement identified.

• It closed at $0.45 on August 11, 2026, after the regular session gained 3.39%.
• The move followed Q2 2026 earnings and positive MIRACLE interim data showing a 37% composite complete remission rate among evaluable patients.
• Profit-taking or thin extended-hours liquidity may be factors, but causation remains uncertain.